KD Logo

Taking a Closer Look At AlloVir Inc (ALVR) Following Its Recent Trade

NUE

In a filing, AlloVir Inc revealed its Chief Executive Officer Brainard Diana unloaded Company’s shares for reported $1072.0 on Jul 02 ’24. In the deal valued at $0.72 per share,1,489 shares were sold. As a result of this transaction, Brainard Diana now holds 782,982 shares worth roughly $0.55 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Sinha Vikas sold 939 shares, generating $676 in total proceeds. Upon selling the shares at $0.72, the insider now owns 1,165,394 shares.

Before that, Miller Edward sold 379 shares. AlloVir Inc shares valued at $273 were divested by the General Counsel at a price of $0.72 per share. As a result of the transaction, Miller Edward now holds 220,117 shares, worth roughly $0.15 million.

BofA Securities downgraded its AlloVir Inc [ALVR] rating to an Underperform from a a Buy in a research note published on December 26, 2023; the price target was decreased to $1 from $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late December from “an Overweight” to “a Neutral”. Leerink Partners also remained covering ALVR and has decreased its forecast on December 22, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on December 22, 2023. It rated ALVR as “an Underweight” which previously was an “an Overweight”.

Price Performance Review of ALVR

On Friday, AlloVir Inc [NASDAQ:ALVR] saw its stock fall -4.75% to $0.70. Over the last five days, the stock has lost -10.24%. AlloVir Inc shares have risen nearly 2.99% since the year began. Nevertheless, the stocks have fallen -78.05% over the past one year. While a 52-week high of $3.79 was reached on 04/01/24, a 52-week low of $0.58 was recorded on 05/13/24. SMA at 50 days reached $0.7671, while 200 days put it at $1.1141. A total of 0.57 million shares were traded, compared to the trading of 0.22 million shares in the previous session.

Levels Of Support And Resistance For ALVR Stock

The 24-hour chart illustrates a support level at 0.6847, which if violated will result in even more drops to 0.6694. On the upside, there is a resistance level at 0.7308. A further resistance level may holdings at 0.7616. The Relative Strength Index (RSI) on the 14-day chart is 39.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0215, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics%K at 18.73% indicates the stock is a buying.

The most recent change occurred on August 18, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.

Most Popular